Loading chat...
CT SB00370
Bill
Status
Introduced
1/23/2019
Primary Sponsor
Martin Looney
Click for details
AI Summary
- Establishes a prescription drug review board in Connecticut to investigate spikes in prescription drug pricing
- Increases transparency in prescription drug pricing through board oversight and investigation
- Bill referred to Committee on PUBLIC HEALTH
- Introduced by Senator Looney, 11th District
- Proposed for January Session, 2019
Legislative Description
An Act Establishing A Prescription Drug Review Board.
Last Action
Change of Reference, House to Committee on Insurance and Real Estate
2/6/2019
Committee Referrals
Insurance and Real Estate2/1/2019
Public Health1/23/2019
Full Bill Text
No bill text available